Top News
Latest News
REGULATORY
15 Jan 2026
FDA opens smoother lanes for CRISPR firmsPARTNERSHIPS
13 Jan 2026
CRISPR tries to crack the rare-disease problemINNOVATION
9 Jan 2026
Why Gene Editing Suddenly Feels InevitablePARTNERSHIPS
16 Dec 2025
A 2021 Gene Editing Deal Still Shapes the Future of Cancer Care
CRISPR Breakthrough Brings Gene Editing Closer to Daily Care
INNOVATION
12 Dec 2025
New trial results suggest gene editing could move from rare use to everyday medicine, pending regulators
REGULATORY
15 Jan 2026
FDA opens smoother lanes for CRISPR firms
FDA manufacturing flexibility could ease early CRISPR development, with industry watchers expecting effects on strategy and investor senti...
PARTNERSHIPS
13 Jan 2026
CRISPR tries to crack the rare-disease problem
Aurora Therapeutics launches with $16M, aiming to turn CRISPR gene editing into a repeatable model for rare disease treatments
INNOVATION
9 Jan 2026
Why Gene Editing Suddenly Feels Inevitable
New startups, regulatory flexibility, and major deals are accelerating US gene editing from niche research to scalable, clinically relevan...
PARTNERSHIPS
16 Dec 2025
A 2021 Gene Editing Deal Still Shapes the Future of Cancer Care
A partnership announced in 2021 between CRISPR Therapeutics and Nkarta continues to frame industry discussions on scalable, off-the-shelf ...
INNOVATION
12 Dec 2025
CRISPR Breakthrough Brings Gene Editing Closer to Daily Care
New trial results suggest gene editing could move from rare use to everyday medicine, pending regulators
TECHNOLOGY
10 Dec 2025
AI Turbocharges Metagenomi’s CRISPR Quest
Metagenomi adopts AWS Inferentia to speed CRISPR discovery and reshape gene editing
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.